Tisch MSRCNY Completes Treatment Phase of FDA-Approved Phase I Stem Cell Trial for MS

Tisch MSRCNY is excited to announce that as of September 14, 2016, all 20 patients in our FDA approved Phase I stem cell clinical trial have received their final treatment! Results will be analyzed and presented at our annual patient symposium on October 16th, 2016 at the New York Hilton Midtown. We will submit for publication in leading scientific journals in the near future!